Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA Meetings, Conferences and Workshops

FDA Meetings, Conferences and Workshops

                        FDA Meetings, Conferences, and Workshops: Past Events
          FDA Annual Reports on Conferences


                        Public Calendar - Meetings With FDA Officials Home
          News & Events
          FDA Meetings, Conferences and Workshops
          2020 FDA-Held Conferences with Expenses Over $100,000FDA Meetings, Conferences and Workshops 2020 FDA-Held Conferences with Expenses Over $100,000
  
  	
    Share
    Post
    Linkedin

    Email
    PrintGeneral Report

The Food and Drug Administration (FDA) hosted 2 conferences with expenditures greater than $100,000 this fiscal year. The FDA funded the conference, travel and other expenses for 498 FDA employees, 106 Federal employees and 392 Non-Federal employees. Conference sponsors included Office of Commissioner and Center for Drug Evaluation and Research conference topics included but were not limited to ensuring the safety and efficacy of prescription, generic, and over-the-counter- drug products that are available to the American public and recent policies related to compounding issued by FDA; CGMP for outsourcing facilities; process design and use of automation technology by outsourcing facilities; FDA inspectional process for outsourcing facilities; and interactions with FDA during and after inspections. All conferences funded and attended followed the applicable Federal authorities, policies and procedures. Furthermore, the conferences helped advanced FDA’s public health mission related to drug compounding and process on outsourcing facilities.

Narrative Report

See below for a summation of all conference expenditures for FY 2020.

Total Conference Net Expenses (in dollars): $429,054.60

Conference Report 1

**Basic Information**

Conference Title: **FDA20 Intergovernmental Working Meeting on Drug Compounding**
Applicable Conference Type: Scientific, FDA Hosted/Sponsored/Co-Sponsored
Conference Location: FDA White Oak Campus, Silver Spring, Maryland
Conference Start Date: 10/10/2019
Conference End Date: 10/11/2019

**Cost and Attendee Information**

Total agency cost of the conference: $130,192.6
Total number of individuals whose travel expenses were paid by the agency: 84

**Explanation of how the conference advanced the mission of the agency**

The FDA Human Drug Program is responsible for ensuring the safety and efficacy of prescription, generic, and over-the-counter drug products that are available to the American public. This meeting provided a forum for both FDA and state officials to collaborate and reach consensus regarding the best way to provide oversight of compounding pharmacies in the future.

Conference Report 2

**Basic Information**

Conference Title: **FDA20 Reducing Risks of Compounded Drugs Engagement with Outsourcing Facilities Conference**
Applicable Conference Type: Scientific, FDA Hosted/Sponsored/Co-Sponsored
Conference Location: Virtual
Conference Start Date: 9/21/2020
Conference End Date: 9/22/2020

**Cost and Attendee Information**

Total agency cost of the conference: $298,862
Total number of individuals whose travel expenses were paid by the agency: None/ Virtual Conference

**Explanation of how the conference advanced the mission of the agency**

Various offices within the FDA work together to advance FDA’s public health mission related to drug compounding. Although compounded drugs can serve an important medical need for certain patients when an approved drug is not medically appropriate, they also present a risk to patients. Compounded drugs are not FDA-approved. Therefore, they do not undergo premarket review by FDA for safety, effectiveness, and quality. The Drug Quality and Security Act of 2013 created “outsourcing facilities” – a new industry sector of drug compounders held to higher quality standards to protect patient health.

                                                                                  Content current as of:
      01/28/2021FDA Meetings, Conferences and Workshops

          
                        FDA Meetings, Conferences, and Workshops: Past Events
          FDA Annual Reports on Conferences


                        Public Calendar - Meetings With FDA Officials
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop